hydroxyindoleacetic acid has been researched along with Liver Neoplasms in 100 studies
(5-hydroxyindol-3-yl)acetic acid : A member of the class of indole-3-acetic acids that is indole-3-acetic acid substituted by a hydroxy group at C-5.
Liver Neoplasms: Tumors or cancer of the LIVER.
Excerpt | Relevance | Reference |
---|---|---|
"The urinary excretion of 5-hydroxyindoleacetic acid, 5-hydroxytryptophan, serotonin, tryptamine, and tyramine and the serum serotonin concentration were determined in 38 consecutive patients with metastatic carcinoid tumors." | 7.66 | Serotonin metabolism in patients with carcinoid tumors: incidence of 5-hydroxytryptophan-secreting tumors. ( Feldman, JM, 1978) |
" Carcinoid tumors with liver metastases, especially those of midgut origin, produce serotonin via the precursors tryptophan and 5-hydroxytryptophan (5-HTP) and this overproduction contributes to the clinical symptoms of the carcinoid syndrome." | 5.07 | Positron emission tomography (PET) in neuroendocrine gastrointestinal tumors. ( Ahlström, H; Bergström, M; Eriksson, B; Långström, B; Lilja, A; Oberg, K, 1993) |
"5-Hydroxyindoleacetic acid (5-HIAA) is used for the evaluation of neuroendocrine tumors (NETs) but currently requires a 24-hour urine collection." | 3.79 | A single fasting plasma 5-HIAA value correlates with 24-hour urinary 5-HIAA values and other biomarkers in midgut neuroendocrine tumors (NETs). ( Mamikunian, G; O'Dorisio, TM; Tellez, MR; Vinik, AI; Woltering, EA, 2013) |
"To correlate clinical and laboratory variables in carcinoid heart disease, clinical data, echocardiograms, 24-hour urinary 5-hydroxyindoleacetic acid levels and liver function tests were evaluated in 30 patients with the carcinoid syndrome." | 3.67 | Clinical and echocardiographic comparison of patients with the carcinoid syndrome with and without carcinoid heart disease. ( Himelman, RB; Schiller, NB, 1989) |
"The urinary excretion of 5-hydroxyindoleacetic acid, 5-hydroxytryptophan, serotonin, tryptamine, and tyramine and the serum serotonin concentration were determined in 38 consecutive patients with metastatic carcinoid tumors." | 3.66 | Serotonin metabolism in patients with carcinoid tumors: incidence of 5-hydroxytryptophan-secreting tumors. ( Feldman, JM, 1978) |
"Midgut carcinoid tumours often present with widespread disease making curative surgery impossible." | 2.71 | Randomized clinical trial of the effect of interferon alpha on survival in patients with disseminated midgut carcinoid tumours. ( Ahrén, B; Franzén, S; Kölby, L; Persson, G, 2003) |
"Mid-gut carcinoid tumours often present with liver metastases, and survival has then been less than 2 years in earlier reports." | 2.68 | Interferon-alpha 2b, with or without prior hepatic artery embolization: clinical response and survival in mid-gut carcinoid patients. The Norwegian carcinoid study. ( Bergan, A; Hanssen, LE; Jacobsen, MB; Kolmannskog, F; Schrumpf, E; Vatn, MH, 1995) |
"Neuroendocrine tumors are increasingly diagnosed, either incidentally as part of screening processes, or for symptoms, which have commonly been mistaken for other disorders initially." | 2.53 | Neuroendocrine Tumors. ( Basuroy, R; Ramage, JK; Srirajaskanthan, R, 2016) |
"Carcinoid tumors are amine precursor uptake decarboxylase (APUD) omas that arise from enterochromaffin cells throughout the gut." | 2.45 | Carcinoid tumors of the gastrointestinal tract. ( Anand, S; Ghevariya, N; Ghevariya, V; Malieckal, A; Mazumder, M, 2009) |
"The midgut carcinoids have typically slow proliferation and extended disease course, and surgical treatment has become increasingly important for their management." | 2.43 | Management of midgut carcinoids. ( Akerström, G; Hellman, P; Hessman, O; Osmak, L, 2005) |
"The prognosis and treatment of carcinoids vary based on location and histology, and therapy must be tailored to each patient." | 2.43 | Carcinoid tumors. ( Chen, H; Sippel, RS, 2006) |
"Patients with carcinoid tumours require a multidisciplinary approach to their care." | 2.41 | Carcinoid syndrome symposium on treatment modalities for gastrointestinal carcinoid tumours: symposium summary. ( DiFrancesco, LM; Kinnear, S; McEwan, A; McKinnon, JG; Numerow, L; Pasieka, JL; Paterson, A; Rorstad, O; Skogseid, B; Yelle, CA, 2001) |
"Certainly in treatment of the carcinoid tumor surgery has a well-established curative and palliative potential." | 2.36 | Treatment of the carcinoid tumor and the malignant carcinoid syndrome. ( Moertel, CG, 1983) |
"Primary carcinoid tumors of the liver are rare, with fewer than 60 cases currently reported in the English literature." | 1.35 | Primary hepatic carcinoid tumor in children. ( Debski, R; Foley, DS; Ignacio, RC; Nagaraj, HS; Sunil, I, 2008) |
"Cytoreductive therapy for metastatic carcinoid provides symptomatic relief and improvement in overall survival." | 1.34 | Biomarkers predict outcomes following cytoreductive surgery for hepatic metastases from functional carcinoid tumors. ( Alvarado, MD; Jensen, EH; Kvols, L; Lewis, JM; Malafa, M; McLoughlin, JM; Shibata, D; Yeatman, T, 2007) |
" Dose escalation was required in order to control carcinoid symptoms, and the final dosage was 5,950 micrograms/day." | 1.29 | Long-term survival in a patient with malignant carcinoid treated with high-dose octreotide. ( Deguchi, H; Deguchi, K; Iwasaki, E; Kobayashi, T; Murashima, S; Shirakawa, S; Tsuda, M; Tsukada, T, 1994) |
"5-Hydroxyindoleacetic acid and serotonin were elevated." | 1.29 | [Pronounced flush symptoms in carcinoid syndrome without liver metastases]. ( Hammar, CH; Raschka, C; Roth, J, 1994) |
"Seven patients with metastasized midgut carcinoids were treated with intravenous infusion of dacarbazine [dimethyltriazenoimidazole carboxamide (DTIC)] (650 mg/m2) every 4 wk." | 1.29 | Treatment of metastasized midgut carcinoids with dacarbazine. ( Leonhardt, U; Ramadori, G; Ritzel, U; Stöckmann, F, 1995) |
"Of 23 patients, 18 had carcinoid syndrome and 19 had elevated urinary 5-hydroxyindoleacetic acid (5-HIAA) levels." | 1.29 | Transcatheter chemoembolization of progressive carcinoid liver metastasis. ( Breittmayer, F; De Baere, T; Ducreux, M; Elias, D; Indushekar, S; Lasser, P; Roche, A; Rougier, P; Therasse, E, 1993) |
"Abdominal carcinoid tumors are often small and difficult to localize." | 1.29 | SPECT improves accuracy of somatostatin receptor scintigraphy in abdominal carcinoid tumors. ( Angeletti, S; Annibale, B; Danieli, R; Delle Fave, G; Gualdi, G; Schillaci, O; Scopinaro, F; Tavolaro, R, 1996) |
"Resection of small bowel carcinoid tumor is indicated even when the liver is involved by diffuse metastases to prevent the risk of small bowel occlusion, and to promote hepatic chemoembolization as subsequent therapy against the carcinoid syndrome and metastatic spread." | 1.28 | [Resection of carcinoid tumors of the small intestine is still indicated in the presence of disseminated hepatic metastases]. ( Landraud, R; Partensky, C; Souquet, JC; Velecela, E, 1990) |
"The case of a carcinoid tumor with a hepatic metastasis is presented and its clinical as well as its biochemical and its morphological results are evaluated after treatment with octreotide over a seven months period." | 1.28 | [Treatment with octreotide (SMS 201-995) in a case of intestinal carcinoid tumor]. ( Goñi, F; Goñi, MJ; González, A; Llorente, I; Moncada, E; Monreal, M; Oleaga, A; Yoldi, A, 1991) |
"Seventeen patients with malignant carcinoid tumour, ten of whom had the malignant carcinoid syndrome, were treated with recombinant alpha-2b interferon by subcutaneous injection (3 MU per dose) three times per week for a median of 12 weeks (range 4-48)." | 1.28 | Recombinant alpha-2b interferon in patients with malignant carcinoid tumour. ( Basser, RL; Fox, RM; Green, MD; Lieschke, GJ; Sheridan, WP, 1991) |
"Thirteen patients with functioning carcinoid syndrome and hepatic metastases were surgically treated." | 1.27 | Surgical treatment of functioning metastatic carcinoid tumors. ( Adson, MA; Martin, JK; Moertel, CG; Schutt, AJ, 1983) |
"Eight patients with metastatic carcinoid tumors and the carcinoid syndrome were treated with gelatin foam embolization of the hepatic arterial tree." | 1.27 | Embolization of the liver in the management of metastatic carcinoid tumors. ( Bengmark, S; Lunderquist, A; Mårtensson, H; Nobin, A; Owman, T; Sandén, G, 1984) |
"Only one carcinoid tumour was found to have been diagnosed on the evidence of elevated 5-HIAA/u levels." | 1.27 | The value of 5-hydroxyindolacetic acid analysis in urine. A clinical and cost-benefit study. ( Alwmark, A; Lasson, A, 1985) |
"Recurrent and very severe carcinoid symptoms could be observed; a bronchial carcinoid supposingly the primary tumour without characteristic symptoms was removed six years before." | 1.27 | Hepatic artery embolisation--new approach for treatment of malignant carcinoid syndrome. ( Jermendy, G; Kárpáti, P; Kónya, A, 1986) |
"Thirty-six patients with malignant carcinoid tumors were treated with human leukocyte interferon (IFN) im at doses of 3-6 megaunits/day." | 1.27 | Treatment of malignant carcinoid tumors with human leukocyte interferon: long-term results. ( Alm, G; Jonsdottir, B; Lind, E; Lundqvist, G; Magnusson, A; Norheim, I; Oberg, K; Wide, L; Wilander, E, 1986) |
"Seven patients with progressive ileal or caecal carcinoid tumors and liver metastases were treated with human recombinant alpha-interferon (IFN alfa-2b) at a dosage of 2-4 x 10(6) U daily or every other day subcutaneously." | 1.27 | [Treatment of metastasized carcinoid tumor of the ileum and cecum with recombinant alpha-2b interferon]. ( Doberauer, C; Kloke, O; Kurschel, E; Niederle, N; Schmidt, CG, 1987) |
"A unique case of midgut carcinoid with advanced disease, engaging lymph nodes and liver but still accessible to curative surgery, is reported." | 1.27 | The pentagastrin test as an indicator of a cure in surgically treated patients with advanced carcinoid disease. ( Ahlman, H; Dahlström, A; Nilsson, O; Tisell, LE, 1988) |
"There was no clinical evidence of carcinoid syndrome." | 1.25 | 5-Hydroxyindole-secreting rectal carcinoid tumour. ( Cheetham, HD; Murray-Lyon, IM; Sandler, M; Watts, JA; Williams, R, 1972) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 54 (54.00) | 18.7374 |
1990's | 20 (20.00) | 18.2507 |
2000's | 17 (17.00) | 29.6817 |
2010's | 8 (8.00) | 24.3611 |
2020's | 1 (1.00) | 2.80 |
Authors | Studies |
---|---|
Kostiainen, I | 1 |
Karppinen, N | 1 |
Simonen, P | 1 |
Rosengård-Bärlund, M | 1 |
Lindén, R | 1 |
Tarkkanen, M | 1 |
Gordin, D | 1 |
Rapola, J | 1 |
Schalin-Jäntti, C | 1 |
Matikainen, N | 1 |
Gut, P | 1 |
Ruchała, M | 1 |
Chan, DL | 1 |
Dixon, M | 1 |
Law, CHL | 1 |
Koujanian, S | 1 |
Beyfuss, KA | 1 |
Singh, S | 2 |
Myrehaug, S | 1 |
Hallet, J | 1 |
Nadler, A | 1 |
Cukier, M | 1 |
Milot, L | 1 |
Law, CH | 1 |
Sadowski, SM | 1 |
Neychev, V | 1 |
Millo, C | 1 |
Shih, J | 1 |
Nilubol, N | 1 |
Herscovitch, P | 1 |
Pacak, K | 1 |
Marx, SJ | 1 |
Kebebew, E | 1 |
Kinová, S | 1 |
Kovácová, M | 1 |
Caprnda, M | 1 |
Koren, M | 1 |
Basuroy, R | 1 |
Srirajaskanthan, R | 1 |
Ramage, JK | 1 |
Foley, DS | 1 |
Sunil, I | 1 |
Debski, R | 1 |
Ignacio, RC | 1 |
Nagaraj, HS | 1 |
Jackson, LN | 1 |
Chen, LA | 1 |
Larson, SD | 1 |
Silva, SR | 1 |
Rychahou, PG | 1 |
Boor, PJ | 1 |
Li, J | 1 |
Defreitas, G | 1 |
Stafford, WL | 1 |
Townsend, CM | 1 |
Evers, BM | 1 |
Cortés-Espinosa, T | 1 |
de la Cruz-Guillén, A | 1 |
Manzano-Cortés, H | 1 |
Ghevariya, V | 1 |
Malieckal, A | 1 |
Ghevariya, N | 1 |
Mazumder, M | 1 |
Anand, S | 1 |
Figueroa-Vega, N | 1 |
Díaz, A | 1 |
Adrados, M | 1 |
Alvarez-Escolá, C | 1 |
Paniagua, A | 1 |
Aragonés, J | 1 |
Martín-Pérez, E | 1 |
Leskela, S | 1 |
Moreno-Otero, R | 1 |
González-Amaro, R | 1 |
Marazuela, M | 1 |
Tellez, MR | 1 |
Mamikunian, G | 1 |
O'Dorisio, TM | 1 |
Vinik, AI | 1 |
Woltering, EA | 1 |
Kölby, L | 1 |
Persson, G | 1 |
Franzén, S | 1 |
Ahrén, B | 1 |
BIRKENHAEGER, JC | 1 |
VAN DER VEER, JS | 1 |
CHOUFOER, JC | 1 |
QUERIDO, A | 1 |
VAN DER HEUL, RO | 1 |
HOLLANDER, CF | 1 |
VAN RIJSSEL, T | 1 |
Zuetenhorst, JM | 1 |
Valdes Olmos, RA | 1 |
Muller, M | 1 |
Hoefnagel, CA | 1 |
Taal, BG | 4 |
Søndenaa, K | 1 |
Sen, J | 1 |
Heinle, F | 1 |
Fjetland, L | 1 |
Gudlaugsson, E | 1 |
Syversen, U | 1 |
Akerström, G | 2 |
Hellman, P | 2 |
Hessman, O | 1 |
Osmak, L | 1 |
Jaber, WA | 1 |
Klarich, KW | 1 |
van Tuyl, SA | 1 |
van Noorden, JT | 1 |
Timmer, R | 1 |
Stolk, MF | 1 |
Kuipers, EJ | 1 |
Sippel, RS | 1 |
Chen, H | 1 |
Jensen, EH | 1 |
Kvols, L | 1 |
McLoughlin, JM | 1 |
Lewis, JM | 1 |
Alvarado, MD | 1 |
Yeatman, T | 1 |
Malafa, M | 1 |
Shibata, D | 1 |
van der Horst-Schrivers, AN | 1 |
Post, WJ | 1 |
Kema, IP | 1 |
Links, TP | 1 |
Willemse, PH | 1 |
Wymenga, AN | 1 |
de Vries, EG | 1 |
Harris, AL | 1 |
Smith, IE | 1 |
Martin, JK | 1 |
Moertel, CG | 3 |
Adson, MA | 1 |
Schutt, AJ | 2 |
Engstrom, PF | 1 |
Mårtensson, H | 1 |
Nobin, A | 1 |
Bengmark, S | 1 |
Lunderquist, A | 1 |
Owman, T | 1 |
Sandén, G | 1 |
Jacobsen, MB | 2 |
Hanssen, LE | 2 |
Kolmannskog, F | 1 |
Schrumpf, E | 1 |
Vatn, MH | 1 |
Bergan, A | 2 |
Ajani, JA | 1 |
Chesnut, JR | 1 |
Nold, R | 1 |
Frank, M | 1 |
Kajdan, U | 1 |
Trost, U | 1 |
Klose, KJ | 1 |
Arnold, R | 1 |
Deguchi, H | 1 |
Deguchi, K | 1 |
Tsukada, T | 1 |
Murashima, S | 1 |
Iwasaki, E | 1 |
Tsuda, M | 1 |
Kobayashi, T | 1 |
Shirakawa, S | 1 |
Roth, J | 1 |
Raschka, C | 1 |
Hammar, CH | 1 |
Ritzel, U | 1 |
Leonhardt, U | 1 |
Stöckmann, F | 1 |
Ramadori, G | 1 |
Eriksson, B | 2 |
Bergström, M | 1 |
Lilja, A | 1 |
Ahlström, H | 1 |
Långström, B | 1 |
Oberg, K | 4 |
Wängberg, B | 3 |
Geterud, K | 2 |
Nilsson, O | 4 |
Jansson, S | 3 |
Dahlström, A | 4 |
Tylén, U | 4 |
Ahlman, H | 7 |
Therasse, E | 1 |
Breittmayer, F | 1 |
Roche, A | 1 |
De Baere, T | 1 |
Indushekar, S | 1 |
Ducreux, M | 1 |
Lasser, P | 1 |
Elias, D | 1 |
Rougier, P | 1 |
Westberg, G | 1 |
Tisell, L | 1 |
Johansson, V | 1 |
Scherstén, T | 2 |
Schillaci, O | 1 |
Scopinaro, F | 1 |
Angeletti, S | 1 |
Tavolaro, R | 1 |
Danieli, R | 1 |
Annibale, B | 1 |
Gualdi, G | 1 |
Delle Fave, G | 1 |
Zuetenhorst, H | 1 |
Boot, H | 1 |
Valdes Olmos, R | 1 |
Hoefnagel, C | 1 |
Vician, M | 1 |
Zeman, M | 1 |
Herichová, I | 1 |
Juráni, M | 1 |
Blazícek, P | 1 |
Matis, P | 1 |
Ricci, S | 1 |
Antonuzzo, A | 1 |
Galli, L | 1 |
Ferdeghini, M | 1 |
Bodei, L | 1 |
Orlandini, C | 1 |
Conte, PF | 1 |
Pasieka, JL | 1 |
McKinnon, JG | 1 |
Kinnear, S | 1 |
Yelle, CA | 1 |
Numerow, L | 1 |
Paterson, A | 1 |
Rorstad, O | 1 |
DiFrancesco, LM | 1 |
McEwan, A | 1 |
Skogseid, B | 2 |
Fiebiger, W | 1 |
Penz, M | 1 |
Längle, F | 1 |
Kurtaran, A | 1 |
Oberhuber, G | 1 |
Raderer, M | 1 |
Lundström, T | 1 |
Ohrvall, U | 1 |
Tiensuu Janson, E | 1 |
Hoberock, TR | 1 |
Knutson, CO | 1 |
Polk, HC | 1 |
Feldman, JM | 3 |
Hansen, M | 1 |
Hansen, HH | 1 |
Hansen, OP | 1 |
Hainau, B | 1 |
Farndon, JR | 1 |
Sivula, A | 1 |
Sipponen, P | 1 |
Jugdutt, BI | 1 |
Watanabe, M | 1 |
Turner, FW | 1 |
Veenhof, CH | 1 |
de Wit, R | 1 |
Dirix, LY | 1 |
Wagstaff, J | 1 |
Hensen, A | 1 |
Huldij, AC | 1 |
Bakker, PJ | 1 |
Partensky, C | 1 |
Landraud, R | 1 |
Velecela, E | 1 |
Souquet, JC | 1 |
Rönnblom, LE | 1 |
Alm, GV | 1 |
Oberg, KE | 1 |
Goñi, F | 1 |
Oleaga, A | 1 |
Goñi, MJ | 1 |
Monreal, M | 1 |
Yoldi, A | 1 |
González, A | 1 |
Llorente, I | 1 |
Moncada, E | 1 |
Stenqvist, O | 2 |
Caidahl, K | 1 |
Tisell, LE | 3 |
Basser, RL | 1 |
Lieschke, GJ | 1 |
Sheridan, WP | 1 |
Fox, RM | 1 |
Green, MD | 1 |
Odurny, A | 1 |
Birch, SJ | 1 |
Lasson, A | 1 |
Alwmark, A | 1 |
Jermendy, G | 1 |
Kónya, A | 1 |
Kárpáti, P | 1 |
Norheim, I | 2 |
Lind, E | 1 |
Alm, G | 1 |
Lundqvist, G | 2 |
Wide, L | 2 |
Jonsdottir, B | 1 |
Magnusson, A | 1 |
Wilander, E | 1 |
Berstad, T | 1 |
Flatmark, A | 1 |
Doberauer, C | 1 |
Niederle, N | 1 |
Kloke, O | 1 |
Kurschel, E | 1 |
Schmidt, CG | 1 |
Enerbäck, L | 1 |
Granérus, G | 1 |
Persson, S | 1 |
Ahlund, L | 1 |
Martner, J | 1 |
Himelman, RB | 1 |
Schiller, NB | 1 |
Theodorsson, E | 1 |
Leitner, SP | 1 |
Greenberg, P | 1 |
Danieu, LA | 1 |
Michaelson, RA | 1 |
Primack, A | 1 |
Wilson, J | 1 |
O'Connor, GT | 1 |
Engelman, K | 1 |
Hull, E | 1 |
Canellos, GP | 1 |
Battersby, C | 1 |
Egerton, WS | 1 |
Zeitlin, IJ | 1 |
Smith, AN | 1 |
Quickel, KE | 1 |
Marecek, RL | 1 |
Lebovitz, HE | 1 |
Iweze, FI | 1 |
Owen-Smith, M | 1 |
Polak, J | 1 |
Gillett, DJ | 1 |
Smith, RC | 1 |
Plonk, JW | 1 |
Cornette, JC | 1 |
von Studnitz, W | 2 |
Schwartz, MK | 1 |
Hermanutz, KD | 1 |
Bücheler, E | 1 |
Biersack, HJ | 1 |
Broicher, K | 1 |
Hienz, HA | 1 |
Grolleau, JY | 1 |
Hardy, M | 1 |
Hervouet, D | 1 |
Le Bodic, MF | 1 |
Mussini-Montpellier, J | 1 |
Visbecq, J | 1 |
Ricci, C | 1 |
Patrassi, N | 1 |
Massa, R | 1 |
Mineo, C | 1 |
Benedetti-Valentini F, J | 1 |
McDermott, WV | 1 |
Hensle, TW | 1 |
Grahame-Smith, DG | 1 |
Grand, A | 1 |
Bourret, M | 1 |
Loire, R | 1 |
Chapuy, A | 1 |
Aune, S | 1 |
Schistad, G | 1 |
Murray-Lyon, IM | 1 |
Sandler, M | 2 |
Cheetham, HD | 1 |
Watts, JA | 1 |
Williams, R | 1 |
Koblinger, J | 1 |
Schweitzer, F | 1 |
Weithaler, A | 1 |
Warter, J | 1 |
Batzenschlager, A | 1 |
Schirardin, H | 1 |
Grappe, JM | 1 |
Berthier, G | 1 |
Monath, C | 1 |
Gardner, B | 1 |
Dollinger, M | 1 |
Silen, W | 1 |
Back, N | 1 |
O'Reilly, S | 1 |
Schievelbein, H | 1 |
Southwood, WF | 1 |
Blakeney, CM | 1 |
Cullum, PA | 1 |
Kojecký, Z | 1 |
Kodousek, R | 1 |
May, B | 1 |
Bak, IJ | 1 |
Böhle, E | 1 |
Hassler, R | 1 |
Aronsen, KF | 1 |
Steiner, H | 1 |
Pihl, B | 1 |
Zeegen, R | 1 |
Rothwell-Jackson, R | 1 |
Mattingly, TW | 1 |
Andrus, EC | 1 |
Biörck, G | 1 |
Manion, WC | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Phase II Study of Hormone Therapy With Tamoxifen in Patients With Well Differentiated Neuroendocrine Tumors and Hormone Receptor Positive Expression[NCT03870399] | Phase 2 | 23 participants (Actual) | Interventional | 2019-03-13 | Active, not recruiting | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
8 reviews available for hydroxyindoleacetic acid and Liver Neoplasms
Article | Year |
---|---|
Neuroendocrine Tumors.
Topics: Antineoplastic Agents; Antineoplastic Agents, Hormonal; Chromogranin A; Digestive System Surgical Pr | 2016 |
Carcinoid tumors of the gastrointestinal tract.
Topics: Antineoplastic Agents; Carcinoid Tumor; Chemoembolization, Therapeutic; Chromogranins; Diagnostic Im | 2009 |
Management of midgut carcinoids.
Topics: Balloon Occlusion; Carcinoid Tumor; Catheter Ablation; Chromogranin A; Chromogranins; Combined Modal | 2005 |
Carcinoid tumors.
Topics: Antineoplastic Agents, Hormonal; Appendiceal Neoplasms; Carcinoid Heart Disease; Carcinoid Tumor; Hu | 2006 |
Treatment of the carcinoid tumor and the malignant carcinoid syndrome.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Appendectomy; Ap | 1983 |
Carcinoid syndrome symposium on treatment modalities for gastrointestinal carcinoid tumours: symposium summary.
Topics: Algorithms; Appendiceal Neoplasms; Carcinoid Tumor; Gastrointestinal Neoplasms; Humans; Hydroxyindol | 2001 |
Biochemical procedures in different forms of cancer.
Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Acid Phosphatase; Adrenal Gland Neoplasms; Alkaline Phos | 1971 |
Progress report: the carcinoid syndrome.
Topics: 5-Hydroxytryptophan; Antineoplastic Agents; Bradykinin; Diarrhea; Heart Valve Diseases; Humans; Hydr | 1970 |
9 trials available for hydroxyindoleacetic acid and Liver Neoplasms
Article | Year |
---|---|
Randomized clinical trial of the effect of interferon alpha on survival in patients with disseminated midgut carcinoid tumours.
Topics: Adult; Aged; Analysis of Variance; Antineoplastic Agents; Carcinoid Tumor; Disease Progression; Fema | 2003 |
Interferon and meta-iodobenzylguanidin combinations in the treatment of metastatic carcinoid tumours.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoid Tumor; | 2004 |
Interferon-alpha 2b, with or without prior hepatic artery embolization: clinical response and survival in mid-gut carcinoid patients. The Norwegian carcinoid study.
Topics: Carcinoid Tumor; Combined Modality Therapy; Embolization, Therapeutic; Female; Hepatic Artery; Human | 1995 |
Clinical effects of octreotide compared to placebo in patients with gastrointestinal neuroendocrine tumours. Report on a double-blind, randomized trial.
Topics: Adaptation, Psychological; Adult; Aged; Biomarkers, Tumor; Double-Blind Method; Female; Gastrointest | 1995 |
Positron emission tomography (PET) in neuroendocrine gastrointestinal tumors.
Topics: 5-Hydroxytryptophan; Adenoma, Islet Cell; Carbon Radioisotopes; Carcinoid Tumor; Female; Gastrointes | 1993 |
Octreotide acetate long-acting release in patients with metastatic neuroendocrine tumors pretreated with lanreotide.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Carcinoid Tumor; | 2000 |
A dose-escalation study of recombinant interferon-alpha in patients with a metastatic carcinoid tumour.
Topics: Adult; Aged; Bone Neoplasms; Carcinoid Tumor; Dose-Response Relationship, Drug; Female; Humans; Hydr | 1992 |
The effects of octreotide on basal and stimulated hormone levels in patients with carcinoid syndrome.
Topics: Aged; Double-Blind Method; Female; Flushing; Humans; Hydroxyindoleacetic Acid; Insulin; Intestinal N | 1989 |
5-hydroxyindoles and kinins in the carcinoid and dumping syndromes.
Topics: Adult; Blood Pressure; Bradykinin; Bronchial Neoplasms; Carcinoma; Dumping Syndrome; Humans; Hydroxy | 1966 |
83 other studies available for hydroxyindoleacetic acid and Liver Neoplasms
Article | Year |
---|---|
Arterial function, biomarkers, carcinoid syndrome and carcinoid heart disease in patients with small intestinal neuroendocrine tumours.
Topics: Biomarkers; Carcinoid Heart Disease; Carcinoid Tumor; Cross-Sectional Studies; Humans; Hydroxyindole | 2022 |
Evaluation of 5-hydroxyindoloacetic acid excretion in urine in patients with small intestine neuroendocrine neoplasm and carcinoid syndrome treated with somatostatin analogues.
Topics: Aged; Antineoplastic Agents, Hormonal; Female; Humans; Hydroxyindoleacetic Acid; Intestinal Neoplasm | 2019 |
Outcomes of Cytoreductive Surgery for Metastatic Low-Grade Neuroendocrine Tumors in the Setting of Extrahepatic Metastases.
Topics: Aged; Cytoreduction Surgical Procedures; Embolization, Therapeutic; Female; Hepatectomy; Humans; Hyd | 2018 |
Hepatic parenchymal preserving technique in the management of diffuse bilateral neuroendocrine tumour liver metastases: a feasible approach.
Topics: Adult; Aged; Chromogranin A; Feasibility Studies; Female; Hepatectomy; Humans; Hydroxyindoleacetic A | 2014 |
Prospective Study of 68Ga-DOTATATE Positron Emission Tomography/Computed Tomography for Detecting Gastro-Entero-Pancreatic Neuroendocrine Tumors and Unknown Primary Sites.
Topics: Adult; Aged; Aged, 80 and over; Chromogranin A; Female; Humans; Hydroxyindoleacetic Acid; Intestinal | 2016 |
[Management of treatment in patients with neuroendocrine neoplasmas of digestive tract].
Topics: Adult; Antineoplastic Agents; Biomarkers, Tumor; Chromogranin A; Endoscopy, Digestive System; Female | 2015 |
Primary hepatic carcinoid tumor in children.
Topics: Adolescent; Back Pain; Biomarkers, Tumor; Carcinoid Tumor; Chromogranin A; Follow-Up Studies; Hematu | 2008 |
Development and characterization of a novel in vivo model of carcinoid syndrome.
Topics: Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineo | 2009 |
[Clinical images in gastrology. Carcinoid tumor metastatic liver].
Topics: Antineoplastic Agents, Hormonal; Biopsy; Carcinoid Tumor; Female; Hepatectomy; Humans; Hydroxyindole | 2008 |
The association of the angiopoietin/Tie-2 system with the development of metastasis and leukocyte migration in neuroendocrine tumors.
Topics: Angiopoietin-1; Angiopoietin-2; Chemotaxis; Chromogranin A; Digestive System Neoplasms; Female; Flow | 2010 |
A single fasting plasma 5-HIAA value correlates with 24-hour urinary 5-HIAA values and other biomarkers in midgut neuroendocrine tumors (NETs).
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Chromogranin A; Disease Progression; Fasting; Female; Ga | 2013 |
METASTASIZING NEUROBLASTOMA WITH EXCRETION OF 5-HYDROXYINDOLEACETIC ACID, SEROTONIN AND 5-HYDROXYTRYPTOPHAN.
Topics: 5-Hydroxytryptophan; Abdominal Neoplasms; Chromatography; Humans; Hydroxyindoleacetic Acid; Indoleac | 1963 |
METASTASISING ISLET-CELL TUMOUR OF THE PANCREAS ASSOCIATED WITH HYPOGLYCAEMIA AND CARCINOID SYNDROME.
Topics: Adenoma, Islet Cell; Cortisone; Ergot Alkaloids; Humans; Hydroxyindoleacetic Acid; Hypoglycemia; Ind | 1964 |
Chromogranin A, a marker of the therapeutic success of resection of neuroendocrine liver metastases: preliminary report.
Topics: Adult; Aged; Aged, 80 and over; Chromogranin A; Chromogranins; Female; Humans; Hydroxyindoleacetic A | 2004 |
Images in cardiovascular medicine. Carcinoid heart disease.
Topics: Bioprosthesis; Carcinoid Heart Disease; Echocardiography, Doppler; Humans; Hydroxyindoleacetic Acid; | 2006 |
Detection of small-bowel neuroendocrine tumors by video capsule endoscopy.
Topics: Adult; Aged; Carcinoma, Neuroendocrine; Endoscopy, Gastrointestinal; Female; Humans; Hydroxyindoleac | 2006 |
Biomarkers predict outcomes following cytoreductive surgery for hepatic metastases from functional carcinoid tumors.
Topics: Adult; Aged; Biomarkers, Tumor; Carcinoid Tumor; Catheter Ablation; Chromogranin A; Digestive System | 2007 |
Persistent low urinary excretion of 5-HIAA is a marker for favourable survival during follow-up in patients with disseminated midgut carcinoid tumours.
Topics: Alkaline Phosphatase; Biomarkers, Tumor; Carcinoid Tumor; Female; gamma-Glutamyltransferase; Humans; | 2007 |
Tryptophan in the treatment of carcinoid crisis.
Topics: Female; Humans; Hydroxyindoleacetic Acid; Laparotomy; Liver Neoplasms; Malignant Carcinoid Syndrome; | 1983 |
Surgical treatment of functioning metastatic carcinoid tumors.
Topics: Aged; Carcinoid Tumor; Female; Hepatic Artery; Humans; Hydroxyindoleacetic Acid; Ligation; Liver Neo | 1983 |
Tamoxifen therapy for metastatic carcinoid tumor: a negative study.
Topics: Adult; Aged; Carcinoid Tumor; Female; Humans; Hydroxyindoleacetic Acid; Liver Neoplasms; Male; Middl | 1984 |
Embolization of the liver in the management of metastatic carcinoid tumors.
Topics: Aged; Carcinoid Tumor; Embolization, Therapeutic; Female; Hepatic Artery; Humans; Hydroxyindoleaceti | 1984 |
Response to increasing doses of octreotide in a patient with carcinoid syndrome.
Topics: Dose-Response Relationship, Drug; Female; Humans; Hydroxyindoleacetic Acid; Liver Neoplasms; Maligna | 1993 |
[Combined treatment of metastatic endocrine tumors of the gastrointestinal tract with octreotide and interferon-alpha].
Topics: Biomarkers, Tumor; Combined Modality Therapy; Female; Gastrinoma; Gastrins; Gastrointestinal Neoplas | 1994 |
Long-term survival in a patient with malignant carcinoid treated with high-dose octreotide.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bronchial Neoplasms; Carcinoid Tumor; Combined Modal | 1994 |
[Pronounced flush symptoms in carcinoid syndrome without liver metastases].
Topics: Aged; Cecal Neoplasms; Cecum; Diagnosis, Differential; Flushing; Humans; Hydroxyindoleacetic Acid; I | 1994 |
Treatment of metastasized midgut carcinoids with dacarbazine.
Topics: Adult; Aged; Biomarkers, Tumor; Carcinoid Tumor; Dacarbazine; Drug Administration Schedule; Female; | 1995 |
Embolisation therapy in the midgut carcinoid syndrome: just tumour ischaemia?
Topics: Adult; Aged; Combined Modality Therapy; Embolization, Therapeutic; Female; Hepatic Artery; Humans; H | 1993 |
Transcatheter chemoembolization of progressive carcinoid liver metastasis.
Topics: Adult; Aged; Carcinoid Tumor; Catheterization; Chemoembolization, Therapeutic; Cisplatin; Doxorubici | 1993 |
Survival of patients with disseminated midgut carcinoid tumors after aggressive tumor reduction.
Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Carcinoid Tumor; Cause of Death; Clinical Protocols; C | 1996 |
SPECT improves accuracy of somatostatin receptor scintigraphy in abdominal carcinoid tumors.
Topics: Abdominal Neoplasms; Carcinoid Tumor; Female; Humans; Hydroxyindoleacetic Acid; Indium Radioisotopes | 1996 |
Long-term palliation in metastatic carcinoid tumours with various applications of meta-iodobenzylguanidin (MIBG): pharmacological MIBG, 131I-labelled MIBG and the combination.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Antineoplastic Agents; Carcinoid Tumor; Combined Modality Therap | 1999 |
Melatonin content in plasma and large intestine of patients with colorectal carcinoma before and after surgery.
Topics: Aged; Circadian Rhythm; Colon; Colonic Neoplasms; Female; Humans; Hydroxyindoleacetic Acid; Intestin | 1999 |
Malignancy in slow motion: diagnosis of biochemically apparent, but otherwise occult persistent disease 21 years after resection of a carcinoid tumour of the terminal ileum.
Topics: Adult; Biomarkers, Tumor; Biopsy; Carcinoma; Humans; Hydroxyindoleacetic Acid; Ileal Neoplasms; Live | 2001 |
Effect of surgery on the outcome of midgut carcinoid disease with lymph node and liver metastases.
Topics: Biomarkers, Tumor; Carcinoid Tumor; Female; Humans; Hydroxyindoleacetic Acid; Intestinal Neoplasms; | 2002 |
Clinical aspects of invasive carcinoid tumors.
Topics: Adolescent; Adult; Aged; Biopsy; Bronchoscopy; Carcinoid Tumor; Child; Female; Follow-Up Studies; Ga | 1975 |
Serotonin metabolism in patients with carcinoid tumors: incidence of 5-hydroxytryptophan-secreting tumors.
Topics: 5-Hydroxytryptophan; Adult; Aged; Carcinoid Tumor; Female; Gastrointestinal Neoplasms; Humans; Hydro | 1978 |
Combination chemotherapy of an APUDoma. With special reference to the therapeutic value of monitoring hormonal substances.
Topics: Amine Oxidase (Copper-Containing); Antineoplastic Agents; Calcitonin; Drug Therapy, Combination; Fem | 1977 |
The carcinoid syndrome: methods of treatment and recent experience with hepatic artery ligation and infusion.
Topics: Female; Fluorouracil; Heart Failure; Hepatic Artery; Humans; Hydroxyindoleacetic Acid; Ileum; Intest | 1977 |
The effect of hepatic dearterialization and re-dearterialization on carcinoid liver metastases.
Topics: Alanine Transaminase; Alkaline Phosphatase; Aspartate Aminotransferases; Bilirubin; Cholesterol; Fem | 1976 |
Hepatic artery ligation in treatment of carcinoid syndrome.
Topics: Aged; Angiography; Cyclophosphamide; Female; Fluorouracil; Hepatic Artery; Humans; Hydroxyindoleacet | 1975 |
[Resection of carcinoid tumors of the small intestine is still indicated in the presence of disseminated hepatic metastases].
Topics: Aged; Carcinoid Tumor; Female; Follow-Up Studies; Humans; Hydroxyindoleacetic Acid; Intestinal Neopl | 1990 |
Possible induction of systemic lupus erythematosus by interferon-alpha treatment in a patient with a malignant carcinoid tumour.
Topics: Adult; Antibodies, Antinuclear; Appendiceal Neoplasms; Carcinoid Tumor; Female; Humans; Hydroxyindol | 1990 |
[Treatment with octreotide (SMS 201-995) in a case of intestinal carcinoid tumor].
Topics: Aged; Carcinoid Tumor; Drug Evaluation; Humans; Hydroxyindoleacetic Acid; Jejunal Neoplasms; Liver N | 1991 |
Management of disseminated midgut carcinoid tumours.
Topics: Adult; Aged; Carcinoid Tumor; Combined Modality Therapy; Embolization, Therapeutic; Female; Hepatect | 1991 |
Recombinant alpha-2b interferon in patients with malignant carcinoid tumour.
Topics: Adult; Aged; Carcinoid Tumor; Female; Gastrointestinal Neoplasms; Humans; Hydroxyindoleacetic Acid; | 1991 |
Hepatic arterial embolisation in patients with metastatic carcinoid tumours.
Topics: Aged; Angiography; Carcinoid Tumor; Embolization, Therapeutic; Female; Hepatic Artery; Humans; Hydro | 1985 |
The value of 5-hydroxyindolacetic acid analysis in urine. A clinical and cost-benefit study.
Topics: Carcinoid Tumor; Cost-Benefit Analysis; Follow-Up Studies; Humans; Hydroxyindoleacetic Acid; Liver N | 1985 |
Hepatic artery embolisation--new approach for treatment of malignant carcinoid syndrome.
Topics: Carcinoid Tumor; Combined Modality Therapy; Embolization, Therapeutic; Female; Hepatic Artery; Human | 1986 |
Treatment of malignant carcinoid tumors with human leukocyte interferon: long-term results.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoid Tumor; Chorionic Gonadotropin; Female; Fol | 1986 |
[Carcinoid tumors of the gastrointestinal tract. Surgical treatment].
Topics: Adult; Aged; Carcinoid Tumor; Female; Gastrointestinal Neoplasms; Humans; Hydroxyindoleacetic Acid; | 1986 |
[Treatment of metastasized carcinoid tumor of the ileum and cecum with recombinant alpha-2b interferon].
Topics: Adult; Aged; Carcinoid Tumor; Cecal Neoplasms; Combined Modality Therapy; Female; Follow-Up Studies; | 1987 |
The pentagastrin test as an indicator of a cure in surgically treated patients with advanced carcinoid disease.
Topics: Carcinoid Tumor; Female; Follow-Up Studies; Humans; Hydroxyindoleacetic Acid; Ileal Neoplasms; Liver | 1988 |
Two cases of gastric carcinoids: diagnostic and therapeutic aspects.
Topics: Aged; Drug Therapy, Combination; Female; Humans; Hydroxyindoleacetic Acid; Imidazoles; Liver Neoplas | 1988 |
SMS 201-995 and provocation tests in preparation of patients with carcinoids for surgery or hepatic arterial embolization.
Topics: Aged; Embolization, Therapeutic; Female; Hemodynamics; Hepatic Artery; Humans; Hydroxyindoleacetic A | 1988 |
Clinical and echocardiographic comparison of patients with the carcinoid syndrome with and without carcinoid heart disease.
Topics: Adult; Aged; Carcinoid Heart Disease; Echocardiography; Female; Heart Valve Diseases; Humans; Hydrox | 1989 |
Partial remission of carcinoid tumor in response to cyproheptadine.
Topics: Aged; Aged, 80 and over; Carcinoid Tumor; Cyproheptadine; Female; Humans; Hydroxyindoleacetic Acid; | 1989 |
Hepatocellular carcinoma with the carcinoid syndrome.
Topics: Acid Phosphatase; Adult; Albumins; Bile Acids and Salts; Carcinoma, Hepatocellular; Esterases; Fibri | 1971 |
A carcinoid saga.
Topics: Anesthesia, General; Aprotinin; Carcinoid Tumor; Female; Fluorouracil; Hepatectomy; Humans; Hydroxyi | 1974 |
Streptozotocin treatment of metastatic carcinoid tumors.
Topics: Carcinoid Tumor; Humans; Hydroxyindoleacetic Acid; Liver Neoplasms; Lung Neoplasms; Male; Malignant | 1972 |
Carcinoid syndrome treated with streptozotocin.
Topics: Alkaline Phosphatase; Female; Histocytochemistry; Humans; Hydroxyindoleacetic Acid; Liver Neoplasms; | 1972 |
Treatment of the carcinoid syndrome by hemihepatectomy and radical excision of the primary lesion.
Topics: Aged; Cyproheptadine; Diarrhea; Fenclonine; Heart Valve Diseases; Hepatectomy; Humans; Hydroxyindole | 1974 |
Serum prostaglandin F-2 alpha concentration in the carcinoid syndrome.
Topics: Aged; Bronchial Neoplasms; Carcinoid Tumor; Female; Fenclonine; Humans; Hydroxyindoleacetic Acid; In | 1974 |
[Proceedings: Tryptophan hydroxylase inhibition as therapy for carcinoid tumors].
Topics: Carcinoid Heart Disease; Carcinoid Tumor; Constipation; Diarrhea; Eosinophilia; Fenclonine; Humans; | 1972 |
[The radiological diagnosis of carcinoids (author's transl)].
Topics: Angiography; Carcinoid Tumor; Cecal Neoplasms; Gastrointestinal Neoplasms; Humans; Hydroxyindoleacet | 1974 |
[Carcinoid syndrome in primary esophageal tumor].
Topics: Esophageal Neoplasms; Humans; Hydroxyindoleacetic Acid; Liver Neoplasms; Male; Malignant Carcinoid S | 1974 |
[Carcinoid tumors with double ileal and bronchial localization (apropos of a case)].
Topics: Autopsy; Bradykinin; Bronchial Neoplasms; Carcinoid Tumor; Humans; Hydroxyindoleacetic Acid; Ileum; | 1972 |
Carcinoid syndrome in bronchial adenoma.
Topics: Adenoma; Adult; Aged; Bronchial Neoplasms; Carcinoid Tumor; Female; Humans; Hydroxycorticosteroids; | 1973 |
Metastatic carcinoid to the liver treated by hepatic dearterialization.
Topics: Alkaline Phosphatase; Aspartate Aminotransferases; Bilirubin; Celiac Artery; Female; Hepatic Artery; | 1974 |
[Carcinoid tumor of the small intestine complicated by endocardial fibrosis of the right heart].
Topics: Aged; Carcinoid Tumor; Cyanosis; Dyspnea; Endocardial Fibroelastosis; Female; Humans; Hydroxyindolea | 1971 |
Carcinoid liver metastases treated with hepatic dearterialization.
Topics: Adult; Alkaline Phosphatase; Bilirubin; Carcinoid Tumor; Cholesterol; Hepatic Artery; Humans; Hydrox | 1972 |
5-Hydroxyindole-secreting rectal carcinoid tumour.
Topics: Adult; Carcinoid Tumor; Duodenal Ulcer; Female; Fluorouracil; Humans; Hydroxyindoleacetic Acid; Live | 1972 |
[Carcinoid tumor. Special reference to a case of an endocrine active bronchial carcinoid with carcinoid syndrome].
Topics: Anuria; Arthritis; Bronchial Neoplasms; Carcinoid Tumor; Colic; Cyanosis; Dyspnea; Edema; Endocardia | 1971 |
[Ileal carcinoid tumors. Predominant lesions of the left endocardium].
Topics: Angiography; Bradykinin; Chromatography; Endocardium; Heart Neoplasms; Humans; Hydroxyindoleacetic A | 1971 |
Studies of the carcinoid syndrome: its relationship to serotonin, bradykinin, and histamine.
Topics: Adult; Aprotinin; Bradykinin; Epinephrine; Gold Isotopes; Histamine; Humans; Hydroxyindoleacetic Aci | 1967 |
[Carcinoid and the kallikrein-kinin system].
Topics: Aprotinin; Humans; Hydroxyindoleacetic Acid; Kallikreins; Kinins; Liver Neoplasms; Malignant Carcino | 1968 |
Carcinoid tumours.
Topics: Carcinoid Tumor; Deglutition Disorders; Female; Gastrointestinal Hemorrhage; Humans; Hydroxyindoleac | 1969 |
A single hepatic metastasis from bronchial carcinoid treated by right hepatectomy.
Topics: Adenoma; Bronchial Neoplasms; Hepatectomy; Humans; Hydroxyindoleacetic Acid; Liver Neoplasms; Male; | 1970 |
[The enterochromaffin system and clinical consequences of hyperserotonism].
Topics: Biopsy; Chromaffin System; Cyanosis; Depression, Chemical; Female; Heart Failure; Humans; Hydroxyind | 1971 |
Electron microscopical and biochemical studies on the serotonin granules in carcinoid syndrome.
Topics: Aldehydes; Amino Acids; Animals; Blood Platelets; Carcinoid Tumor; Fluorometry; Histamine; Histocyto | 1968 |
Surgical treatment of metastasizing carcinoid tumours.
Topics: Hepatectomy; Humans; Hydroxyindoleacetic Acid; Ileum; Intestinal Neoplasms; Liver Function Tests; Li | 1969 |
Massive hepatic resection for the carcinoid syndrome.
Topics: Adult; Hepatectomy; Humans; Hydroxyindoleacetic Acid; Ileum; Intestinal Neoplasms; Liver Neoplasms; | 1969 |
The functioning carcinoid tumor: a serendipity in diagnosis.
Topics: Adolescent; Adult; Ascites; Child; Female; Heart Failure; Humans; Hydroxyindoleacetic Acid; Ileum; I | 1966 |